JP7002334B2 - 膀胱がんを診断する方法 - Google Patents

膀胱がんを診断する方法 Download PDF

Info

Publication number
JP7002334B2
JP7002334B2 JP2017567208A JP2017567208A JP7002334B2 JP 7002334 B2 JP7002334 B2 JP 7002334B2 JP 2017567208 A JP2017567208 A JP 2017567208A JP 2017567208 A JP2017567208 A JP 2017567208A JP 7002334 B2 JP7002334 B2 JP 7002334B2
Authority
JP
Japan
Prior art keywords
mvp
mvps
seq
nos
methylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017567208A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018520672A5 (https=
JP2018520672A (ja
Inventor
フィーバー、アンドリュー
ケリー、ジョン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Publication of JP2018520672A publication Critical patent/JP2018520672A/ja
Publication of JP2018520672A5 publication Critical patent/JP2018520672A5/ja
Priority to JP2021169917A priority Critical patent/JP2022025090A/ja
Application granted granted Critical
Publication of JP7002334B2 publication Critical patent/JP7002334B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2017567208A 2015-06-24 2016-06-24 膀胱がんを診断する方法 Active JP7002334B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021169917A JP2022025090A (ja) 2015-06-24 2021-10-15 膀胱がんを診断する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1511152.9 2015-06-24
GBGB1511152.9A GB201511152D0 (en) 2015-06-24 2015-06-24 Method of diagnosing bladder cancer
PCT/GB2016/051903 WO2016207656A1 (en) 2015-06-24 2016-06-24 Methods of diagnosing bladder cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021169917A Division JP2022025090A (ja) 2015-06-24 2021-10-15 膀胱がんを診断する方法

Publications (3)

Publication Number Publication Date
JP2018520672A JP2018520672A (ja) 2018-08-02
JP2018520672A5 JP2018520672A5 (https=) 2019-07-25
JP7002334B2 true JP7002334B2 (ja) 2022-02-04

Family

ID=53784470

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017567208A Active JP7002334B2 (ja) 2015-06-24 2016-06-24 膀胱がんを診断する方法
JP2021169917A Pending JP2022025090A (ja) 2015-06-24 2021-10-15 膀胱がんを診断する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021169917A Pending JP2022025090A (ja) 2015-06-24 2021-10-15 膀胱がんを診断する方法

Country Status (8)

Country Link
US (1) US11473148B2 (https=)
EP (1) EP3314016B1 (https=)
JP (2) JP7002334B2 (https=)
CN (1) CN108350504B (https=)
AU (1) AU2016283063B2 (https=)
GB (1) GB201511152D0 (https=)
MA (1) MA42238A (https=)
WO (1) WO2016207656A1 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019022360A2 (pt) 2017-05-18 2020-05-19 Genomic Health, Inc. métodos para monitorar um paciente com câncer de bexiga e para tratar um paciente com câncer de bexiga, sistema para quantificar a metilação de dna, cartucho, kit e composição
WO2019068082A1 (en) * 2017-09-29 2019-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Dna methylation biomarkers for cancer diagnosing
US10975443B2 (en) * 2017-11-30 2021-04-13 Mayo Foundation For Medical Education And Research Detecting breast cancer
CN119753091A (zh) 2018-04-02 2025-04-04 格里尔公司 用于扩增与癌症相关联的cfDNA分子的化验板
CN108588219B (zh) * 2018-04-19 2021-10-26 安徽达健医学科技有限公司 一种用于早期膀胱癌检测的试剂盒及其使用方法
JP2021530214A (ja) * 2018-07-11 2021-11-11 スティヒティング フェーユーエムセー 膀胱がんのための尿ｄｎａメチル化マーカー
IL281741B2 (en) 2018-09-27 2026-04-01 Grail Inc Methylation markers and a targeted methylation detection panel
US20220017966A1 (en) * 2018-11-16 2022-01-20 Oslo Universitetssykehus Hf Methods and compositions for characterizing bladder cancer
CN111206093A (zh) * 2018-11-21 2020-05-29 立森印迹诊断技术（无锡）有限公司 一种用于检测浸润性膀胱癌的标志物及其应用
EP3914736B1 (en) * 2019-01-25 2023-12-20 Grail, LLC Detecting cancer, cancer tissue of origin, and/or a cancer cell type
EP3921445B1 (en) * 2019-02-05 2024-09-04 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
CN109971860B (zh) * 2019-04-30 2022-10-11 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep8及其应用
WO2020227100A1 (en) * 2019-05-03 2020-11-12 Cornell University Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes
US11396679B2 (en) 2019-05-31 2022-07-26 Universal Diagnostics, S.L. Detection of colorectal cancer
US20220251663A1 (en) * 2019-06-14 2022-08-11 Arizona Board Of Regents On Behalf Of The University Of Arizona Dna methylation biomarkers for cancer diagnosing and treatment
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
JP2023516525A (ja) * 2019-12-26 2023-04-20 広州市基准医療有限公司 Ｄｎａメチル化バイオマーカーの組み合わせ、検出方法および試薬キット
CN110872631B (zh) * 2019-12-26 2021-08-10 广州市基准医疗有限责任公司 Dna甲基化生物标志物组合、检测方法和试剂盒
US11851714B2 (en) 2019-12-26 2023-12-26 Anchordx Medical Co., Ltd. Combinations, detection methods and kits of DNA methylation biomarker
CN117248026A (zh) * 2019-12-31 2023-12-19 上海奕谱生物科技有限公司 新型的诊断肿瘤的标志物及其应用
KR102637032B1 (ko) * 2020-01-28 2024-02-15 주식회사 젠큐릭스 특정 유전자의 CpG 메틸화 변화를 이용한 방광암 진단용 조성물 및 이의 용도
CN111635938B (zh) * 2020-04-30 2022-07-29 广州康立明生物科技股份有限公司 一种肿瘤检测试剂及试剂盒
WO2021228418A1 (en) 2020-05-15 2021-11-18 Universal Diagnostics, S.L. Methods and systems for identifying methylation biomarkers
CN111560436A (zh) * 2020-05-28 2020-08-21 郑成云 一种tert突变检测试剂盒及在肿瘤无创诊断中的应用
WO2022002424A1 (en) * 2020-06-30 2022-01-06 Universal Diagnostics, S.L. Systems and methods for detection of multiple cancer types
CN117062915A (zh) * 2021-01-12 2023-11-14 里兰斯坦福初级大学理事会 用于癌症诊断和预后的甲基化生物标志的分层分析
JP7806793B2 (ja) 2021-06-03 2026-01-27 日本精工株式会社 グリースの劣化検知方法
CN113652490B (zh) * 2021-09-27 2022-07-22 广州凯普医药科技有限公司 一种用于膀胱癌早期筛查和/或预后监测的引物探针组合及试剂盒
CN114107513B (zh) * 2022-01-27 2022-05-03 北京优乐复生科技有限责任公司 一种用于膀胱尿路上皮癌诊断的检测方法和试剂盒
CN116042820B (zh) * 2022-09-07 2023-09-29 浙江大学 一组结肠癌dna甲基化分子标志物及其在制备用于结肠癌早期诊断试剂盒中的应用
US12606872B2 (en) 2022-11-16 2026-04-21 Universal Diagnostics, S.A. Methods for stratification and early detection of advanced adenoma and/or colorectal cancer using DNA methylation markers
AU2023433294A1 (en) * 2023-02-21 2025-09-25 Nucleix Ltd. Assessment of hematuria and other urinary tract symptoms
CN116287256A (zh) * 2023-02-22 2023-06-23 苏州维基基因科技有限公司 用于膀胱癌早期诊断的检测试剂盒及其应用
CN116987787B (zh) * 2023-06-09 2024-07-30 北京泛生子基因科技有限公司 检测膀胱癌是否复发的装置和计算机可读存储介质
CN116555432B (zh) * 2023-07-05 2023-09-05 广州凯普医药科技有限公司 一种膀胱癌快速检测试剂盒
CN118006781B (zh) * 2024-02-27 2025-01-07 广州中鑫基因医学科技有限公司 用于检测尿路上皮癌的标志物、引物组、高敏感性和高特异性的试剂盒及检测方法
CN118222710A (zh) * 2024-03-25 2024-06-21 江苏阔然生物医药科技有限公司 检测dmrta2、runx3和twist1基因的甲基化水平的试剂在制备膀胱癌诊断产品中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010123354A2 (en) 2009-04-20 2010-10-28 Erasmus University Medical Center Rotterdam Method of diagnosing bladder cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2669439T3 (es) 2009-06-26 2018-05-25 Epigenomics Ag Métodos y ácidos nucleicos para el análisis del carcinoma de vejiga
US9249467B2 (en) 2011-09-16 2016-02-02 Steven Goodison Bladder cancer detection composition, kit and associated methods
US9096905B2 (en) 2012-02-23 2015-08-04 Medical Diagnostic Laboratories, Llc Detecting DNA methylation of BCL2, CDKN2A and NID2 genes to predict bladder cancer in humans

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010123354A2 (en) 2009-04-20 2010-10-28 Erasmus University Medical Center Rotterdam Method of diagnosing bladder cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Feber, A. et al.，"Using high-density DNA methylation arrays to profile copy number alterations"，Genome Biol.，2014年，Vol. 15; R30，pp. 1-13
Reinert, T.，"Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer"，Adv. Urol.，2012年，Vol. 2012; 503271，pp. 1-11

Also Published As

Publication number Publication date
EP3314016A1 (en) 2018-05-02
AU2016283063A1 (en) 2018-02-08
CN108350504A (zh) 2018-07-31
JP2018520672A (ja) 2018-08-02
EP3314016B1 (en) 2024-05-29
WO2016207656A1 (en) 2016-12-29
CN108350504B (zh) 2023-09-29
JP2022025090A (ja) 2022-02-09
MA42238A (fr) 2018-05-02
US11473148B2 (en) 2022-10-18
US20180305765A1 (en) 2018-10-25
AU2016283063B2 (en) 2022-01-20
GB201511152D0 (en) 2015-08-05

Similar Documents

Publication Publication Date Title
JP7002334B2 (ja) 膀胱がんを診断する方法
He et al. Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer
JP7541365B2 (ja) 大腸がんの検出
WO2012125721A2 (en) Methods and materials for using the contents of phagocytes to detect neoplasms
TWI730429B (zh) Hoxa7甲基化檢測試劑
JP2022516889A (ja) メチル化修飾に基づく腫瘍マーカーｓｔａｍｐ－ｅｐ３
TW202142549A (zh) 腫瘤檢測試劑及試劑盒
AU2020293611A1 (en) Methods of detecting and predicting breast cancer
US20210062268A1 (en) Method of Identifying Metastatic Breast Cancer by Differentially Methylated Regions
US10131953B2 (en) Unbiased DNA methylation markers define an extensive field defect in histologically normal prostate tissues associated with prostate cancer: new biomarkers for men with prostate cancer
US12606872B2 (en) Methods for stratification and early detection of advanced adenoma and/or colorectal cancer using DNA methylation markers
WO2018158589A1 (en) Diagnostic and prognostic methods
WO2017119510A1 (ja) 乳がんの診断のための検査方法、遺伝子マーカー、および検査薬
JP2023500923A (ja) 大腸癌検出方法
JP5986746B2 (ja) 生体試料中の上皮性癌由来の細胞の存否を判定するための方法、分子マーカー及びキット
JP2023530984A (ja) グレード３子宮頸部上皮腫瘍（ｃｉｎ３）および／またはがんを検出および予測するための方法
WO2023082139A1 (zh) 一种用于诊断肝癌的核酸及蛋白检测试剂盒
CN116783309A (zh) 用于检测和预测癌症和/或cin3的方法
AU2021291134A1 (en) Methods for detecting and predicting cancer
JP2015177745A (ja) 肺癌の検査方法
JP2026513346A (ja) 腫瘍検出方法及び試薬
WO2024207698A1 (zh) 肿瘤的检测方法及试剂
WO2026082917A1 (en) Methods for detecting breast cancer
JP2025537955A (ja) 食道癌及び胃癌診断用ｄｎａメチル化マーカー及びその用途

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20180508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190620

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190620

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200707

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201002

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210107

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210615

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211015

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20211015

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20211018

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20211115

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20211116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20211207

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211227

R150 Certificate of patent or registration of utility model

Ref document number: 7002334

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250